# Novocol Pharmaceutical of Canada, Inc. – FDA Inspection, Jun 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/5a9546ca-45e2-4264-a4d2-5e3257507745
Source feed: FDA_Inspections

> FDA inspection 1093310 of Novocol Pharmaceutical of Canada, Inc., June 18, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1093310
- Company Name: Novocol Pharmaceutical of Canada, Inc.
- Inspection Date: 2019-06-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1243223 - 2024-05-03
- FDA Inspection 1117454 - 2020-01-30
- FDA Inspection 1098218 - 2019-06-21
- FDA Inspection 1072908 - 2018-11-02
- [FDA Inspection 1019963 - 2017-07-26](https://www.keypedia.com/records/fda_inspections/novocol-pharmaceutical-of-canada-inc/da862aae-318c-4735-bb6c-6b113e69b6ce)

## Related Officers

- [Bei Y. He](https://www.keypedia.com/people/bei-y-he/6ee057b7-9558-4f4c-b312-9a63821699c2)

Company: https://www.keypedia.com/companies/novocol-pharmaceutical-of-canada-inc/28ac0d84-7b4b-4be0-96a8-9daeafbb5ac3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
